{
  "generated": "2025-11-06T07:07:41.289692+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/metabolic/berberine-meta-gen-0441/metabolic/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "META-GEN-0441_01",
      "year": 2015,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "blood_sugar",
      "population": "Adults with blood sugar concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/berberine-meta-gen-0441-01",
      "url": "https://doi.org/10.1234/berberine-meta-gen-0441-01",
      "citation": "META-GEN-0441_01 (2015); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with blood sugar concerns; Outcome: blood_sugar; DOI: 10.1234/berberine-meta-gen-0441-01; Adverse Events: Transient headache."
    },
    {
      "study_id": "META-GEN-0441_02",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "blood_sugar",
      "population": "Adults with blood sugar concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/berberine-meta-gen-0441-02",
      "url": "https://doi.org/10.1234/berberine-meta-gen-0441-02",
      "citation": "META-GEN-0441_02 (2016); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with blood sugar concerns; Outcome: blood_sugar; DOI: 10.1234/berberine-meta-gen-0441-02; Adverse Events: None reported."
    },
    {
      "study_id": "META-GEN-0441_03",
      "year": 2017,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "blood_sugar",
      "population": "Adults with blood sugar concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/berberine-meta-gen-0441-03",
      "url": "https://doi.org/10.1234/berberine-meta-gen-0441-03",
      "citation": "META-GEN-0441_03 (2017); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with blood sugar concerns; Outcome: blood_sugar; DOI: 10.1234/berberine-meta-gen-0441-03; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/berberine-meta-gen-0441-01",
      "study_ids": [
        "META-GEN-0441_01"
      ],
      "primary_study_id": "META-GEN-0441_01",
      "url": "https://doi.org/10.1234/berberine-meta-gen-0441-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/berberine-meta-gen-0441-02",
      "study_ids": [
        "META-GEN-0441_02"
      ],
      "primary_study_id": "META-GEN-0441_02",
      "url": "https://doi.org/10.1234/berberine-meta-gen-0441-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/berberine-meta-gen-0441-03",
      "study_ids": [
        "META-GEN-0441_03"
      ],
      "primary_study_id": "META-GEN-0441_03",
      "url": "https://doi.org/10.1234/berberine-meta-gen-0441-03"
    }
  ],
  "manifest_hash": "sha256:5d1e641b62759fa245c2e85472e9b20125d33fb194e4c6de6f11c6dd319d18e9"
}
